Cargando…
Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli
Anti-CRISPR proteins (Acrs) block the activity of CRISPR-associated (Cas) proteins, either by inhibiting DNA interference or by preventing crRNA loading and complex formation. Although the main use of Acrs in genome engineering applications is to lower the cleavage activity of Cas proteins, they can...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576004/ https://www.ncbi.nlm.nih.gov/pubmed/37833505 http://dx.doi.org/10.1038/s42003-023-05418-5 |
_version_ | 1785121033758441472 |
---|---|
author | Trasanidou, Despoina Potocnik, Ana Barendse, Patrick Mohanraju, Prarthana Bouzetos, Evgenios Karpouzis, Efthymios Desmet, Amber van Kranenburg, Richard van der Oost, John Staals, Raymond H. J. Mougiakos, Ioannis |
author_facet | Trasanidou, Despoina Potocnik, Ana Barendse, Patrick Mohanraju, Prarthana Bouzetos, Evgenios Karpouzis, Efthymios Desmet, Amber van Kranenburg, Richard van der Oost, John Staals, Raymond H. J. Mougiakos, Ioannis |
author_sort | Trasanidou, Despoina |
collection | PubMed |
description | Anti-CRISPR proteins (Acrs) block the activity of CRISPR-associated (Cas) proteins, either by inhibiting DNA interference or by preventing crRNA loading and complex formation. Although the main use of Acrs in genome engineering applications is to lower the cleavage activity of Cas proteins, they can also be instrumental for various other CRISPR-based applications. Here, we explore the genome editing potential of the thermoactive type II-C Cas9 variants from Geobacillus thermodenitrificans T12 (ThermoCas9) and Geobacillus stearothermophilus (GeoCas9) in Escherichia coli. We then demonstrate that the AcrIIC1 protein from Neisseria meningitidis robustly inhibits their DNA cleavage activity, but not their DNA binding capacity. Finally, we exploit these AcrIIC1:Cas9 complexes for gene silencing and base-editing, developing Acr base-editing tools. With these tools we pave the way for future engineering applications in mesophilic and thermophilic bacteria combining the activities of Acr and CRISPR-Cas proteins. |
format | Online Article Text |
id | pubmed-10576004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105760042023-10-15 Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli Trasanidou, Despoina Potocnik, Ana Barendse, Patrick Mohanraju, Prarthana Bouzetos, Evgenios Karpouzis, Efthymios Desmet, Amber van Kranenburg, Richard van der Oost, John Staals, Raymond H. J. Mougiakos, Ioannis Commun Biol Article Anti-CRISPR proteins (Acrs) block the activity of CRISPR-associated (Cas) proteins, either by inhibiting DNA interference or by preventing crRNA loading and complex formation. Although the main use of Acrs in genome engineering applications is to lower the cleavage activity of Cas proteins, they can also be instrumental for various other CRISPR-based applications. Here, we explore the genome editing potential of the thermoactive type II-C Cas9 variants from Geobacillus thermodenitrificans T12 (ThermoCas9) and Geobacillus stearothermophilus (GeoCas9) in Escherichia coli. We then demonstrate that the AcrIIC1 protein from Neisseria meningitidis robustly inhibits their DNA cleavage activity, but not their DNA binding capacity. Finally, we exploit these AcrIIC1:Cas9 complexes for gene silencing and base-editing, developing Acr base-editing tools. With these tools we pave the way for future engineering applications in mesophilic and thermophilic bacteria combining the activities of Acr and CRISPR-Cas proteins. Nature Publishing Group UK 2023-10-13 /pmc/articles/PMC10576004/ /pubmed/37833505 http://dx.doi.org/10.1038/s42003-023-05418-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Trasanidou, Despoina Potocnik, Ana Barendse, Patrick Mohanraju, Prarthana Bouzetos, Evgenios Karpouzis, Efthymios Desmet, Amber van Kranenburg, Richard van der Oost, John Staals, Raymond H. J. Mougiakos, Ioannis Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title | Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title_full | Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title_fullStr | Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title_full_unstemmed | Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title_short | Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli |
title_sort | characterization of the acriic1 anti‒crispr protein for cas9‒based genome engineering in e. coli |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576004/ https://www.ncbi.nlm.nih.gov/pubmed/37833505 http://dx.doi.org/10.1038/s42003-023-05418-5 |
work_keys_str_mv | AT trasanidoudespoina characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT potocnikana characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT barendsepatrick characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT mohanrajuprarthana characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT bouzetosevgenios characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT karpouzisefthymios characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT desmetamber characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT vankranenburgrichard characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT vanderoostjohn characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT staalsraymondhj characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli AT mougiakosioannis characterizationoftheacriic1anticrisprproteinforcas9basedgenomeengineeringinecoli |